A multicenter, randomized, double-blind, placebo- and active-controlled study of DVS-233 [desvenlafaxine; Pristiq] SR [slow release] for treatment of vasomotor symptoms associated with menopause

Trial Profile

A multicenter, randomized, double-blind, placebo- and active-controlled study of DVS-233 [desvenlafaxine; Pristiq] SR [slow release] for treatment of vasomotor symptoms associated with menopause

Completed
Phase of Trial: Phase III

Latest Information Update: 14 May 2007

At a glance

  • Drugs Desvenlafaxine; Tibolone
  • Indications Hot flashes; Menopausal syndrome; Menopause
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 14 May 2007 Status changed from recruiting to completed.
    • 09 May 2007 Results have been published
    • 08 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top